Takeda Pharmaceutical Co Ltd (FRA:TKD)
€ 25.61 0.16 (0.63%) Market Cap: 40.44 Bil Enterprise Value: 65.50 Bil PE Ratio: 23.27 PB Ratio: 0.97 GF Score: 82/100

Takeda Pharmaceutical Co Ltd at JPMorgan Healthcare Conference Transcript

Jan 09, 2024 / 01:15AM GMT
Release Date Price: €26.8 (-0.59%)
Seiji Wakao
JPMorgan Chase & Co, Research Division - VP

Welcome to JPMorgan Healthcare Conference. I'm Seiji Wakao, Japan pharma analyst. We will conduct this session via fireside chat form. And James Gordon will lead the fireside chat. He's a European pharma analyst. And he and I will be covering Takeda.

And I'd like to introduce the speakers from Takeda: Christophe Weber, President and CEO; Andy Plump, President, R&D; and Costa Saroukos, CFO; Ramona Sequeira, President, Global Portfolio division; and Julie Kim, President, U.S. Business Unit.

Let me turn it over to James.

James Daniel Gordon
JPMorgan Chase & Co, Research Division - Senior Analyst

Good evening, everyone. I'm James Gordon. As mentioned, I'm a pharma analyst at JPMorgan. Along with Wakao, we both look at Takeda. And the plan for today is we're going to have a fireside chat. So I'm going to go for a couple of questions with the team. And then we both may have some further questions as well, and we'll leave time to take your questions from the audience.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot